Cargando…

Palliative extracranial radiotherapy in patients receiving immunotherapy for non-small cell lung cancer: a narrative review

BACKGROUND AND OBJECTIVE: Role of radiotherapy (RT) in the era of immuno-oncology (IO) in advanced non-small cell lung cancer (NSCLC) is rapidly changing. RT is not only intended for addressing palliation symptoms but also is considered as a potential tool potentializing an immunogenic effect of giv...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kępka, Lucyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906063/ https://www.ncbi.nlm.nih.gov/pubmed/36760380 http://dx.doi.org/10.21037/tcr-22-1969

Ejemplares similares

Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer
por: Chodavadia, Parth A., et al.
Publicado: (2021)

Dose and fractionation schedules in radiotherapy for non-small cell lung cancer
por: Kepka, Lucyna, et al.
Publicado: (2021)

Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2020)

Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review
por: Xia, Wu-Yan, et al.
Publicado: (2020)

A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer
por: Akanda, Zarique Z., et al.
Publicado: (2021)

Radiotherapy for brain metastases from small-cell lung cancer in distinct clinical indications and scenarios
por: Kepka, Lucyna, et al.
Publicado: (2021)

A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
por: Zhou, Yue, et al.
Publicado: (2020)

Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
por: Sundahl, Nora, et al.
Publicado: (2021)

Early palliative care of non-small cell lung cancer in the context of immunotherapy
por: Pieniążek, Małgorzata, et al.
Publicado: (2020)

Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review
por: Gatteschi, Lavinia, et al.
Publicado: (2021)

Prophylactic cranial irradiation in non-small cell lung cancer: evidence and future development
por: Chalubinska-Fendler, Justyna, et al.
Publicado: (2021)

Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?—a narrative review by the international geriatric radiotherapy group
por: Vinh-Hung, Vincent, et al.
Publicado: (2022)

Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy
por: Guo, Tiantian, et al.
Publicado: (2020)

Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
por: Ampil, Federico L., et al.
Publicado: (2011)

Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review
por: Montrone, Michele, et al.
Publicado: (2023)

Thoracic radiotherapy in small cell lung cancer—a narrative review
por: Levy, Antonin, et al.
Publicado: (2021)

Addressing the challenge of proper delineation of lymph node stations in modern radiotherapy for lung cancer
por: Kępka, Lucyna, et al.
Publicado: (2018)

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Neoadjuvant immunotherapy in non-small cell lung cancer: a narrative review on mechanisms, efficacy and safety
por: Shao, Lan, et al.
Publicado: (2022)

Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
por: Støchkel Frank, Malene, et al.
Publicado: (2018)

Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy
por: Son, Christine, et al.
Publicado: (2023)

An Update on the Quality of Life Measurements in Lung Cancer Patients Receiving Palliative Radiotherapy: A Literature Review
por: Chu, Dominic, et al.
Publicado: (2013)

Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature review
por: Lin, Xinqing, et al.
Publicado: (2019)

Quality of life measurement in cancer patients receiving palliative radiotherapy for symptomatic lung cancer: a literature review
por: Salvo, N., et al.
Publicado: (2009)

Response to “Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?”
por: Kepka, Lucyna, et al.
Publicado: (2021)

A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer
por: Prasad, Rahul N., et al.
Publicado: (2020)

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021)

The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review
por: Ning, Xiangu, et al.
Publicado: (2021)

Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2020)

Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
por: Quiñones-Avila, Valerie, et al.
Publicado: (2021)

Early High-Grade Thoracic Toxicity After Palliative Radiotherapy for Non-Small Cell Lung Cancer
por: Nieder, Carsten, et al.
Publicado: (2021)

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy
por: Canale, Maria Laura, et al.
Publicado: (2020)

Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?
por: Spaas, Mathieu, et al.
Publicado: (2019)

Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
por: Onn, Amir, et al.
Publicado: (2021)

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shang, Shijie, et al.
Publicado: (2021)

Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer
por: Suwinski, Rafal
Publicado: (2021)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Sex dimorphism in response to targeted therapy and immunotherapy in non-small cell lung cancer patients: a narrative review
por: Huang, Yingbo, et al.
Publicado: (2022)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

International consensus on radiotherapy in metastatic non-small cell lung cancer
por: Zhu, Zhengfei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m4238jkblg6tmfob2k4ddi8kbf